Combination therapy promoted IFNγ production by CD4+ T cells in the tumor and CD8+ T cells in the spleen and granzyme B production by CD8+ T cells in the tumor (Fig. 6i, Additional file 1: S4A). The gene discussed is GZMB; the disease is neoplasm.